PPT-In-Hospital Mortality in Patients with COVID-19 Treated with Hydroxychloroquine and/or

Published Data Multicenter Retrospective Cohort Source Rosenberg ES et al JAMA 2020 May 11e208630 InHospital Mortality in Patients with COVID19 Treated with Hydroxychloroquine andor Azithromycin. Obesity is paradoxically associated with favorable mortality outcomes in acute myocardial infarction (AMI).. Association between obesity & in-hospital mortality among patients with cardiogenic shock (CS) complicating AMI (N=290,894) was retrospectively studied.. Number needed to treat-MDA. Number needed to treat via MDA to avert 1 death. = . . = . = 526.  . Keenan, NEJM, 2018. MDA . Number needed to treat-Targeted. Number needed to treat via MDA to avert 1 death. 10 State Department of HealthMissouri Hospital Industry Data InstituteMontana Hospital AssociationNebraskaHospital AssociationWashingtonState Department of HealthWest VirginiaDepartment of Health and GuidingfromtheAmericanCollegeofRheumatologyforScarceResourceAllocationDuringtheCOVID-19PandemicTheCaseofHydroxychloroquineBackgroundEthicalprinciplesmustbebalancedwhenmakingdecisionsaboutscarceresourc Andreas J . Deymann. , MD. Chair of the Department of Pediatrics . Memorial Hospital South Bend. Justin Chow, MD, FACP, . FHM. Hospitalist. Director . of Mid-Level Program of Hospitalist Department. Memorial Hospital South Bend. Paul Reynolds, PharmD, BCCCP. Matthew Miller, PharmD, BCIDP. Gina Moore, PharmD, MBA. March 20, 2020. Learning Objectives. Identify the unique clinical and epidemiological characteristics of Coronavirus (COVID-19) in the spectrum of viral clinical illnesses and previous Coronavirus (SARS, MERS) and non-Coronavirus (influenza, common cold) related illnesses. Eli Opacich, . PharmD. , BCPS, BCCCP. December 2. nd. 2020. Financial Disclosures:. None. Learning Objectives. Assess pharmacotherapy updates in sepsis and septic shock . Employ antimicrobial stewardship practices related . 1763 Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective Matthew J Cummings, Matthew R Baldwin, Darryl Abrams, 000 patients with COVID-19 Dr Akmal Hafizah Zamli. Consultant Rehabilitation Physician. Head of Rehabilitation Medicine Department. Hospital Sungai Buloh. Selangor, MALAYSIA. . WORLD HEALTH ORGANIZATION GLOBAL WEBINAR SERIES. Mark . Sonderup and Douglas LaBrecque*. Division of Hepatology, Department of Medicine, . University of Cape Town and Groote Schuur Hospital. Cape Town, South . Africa. *Emeritus Professor of Internal Medicine, Gastroenterology and Hepatology. M. Safwan Badr, MD, MBA. Professor and Chair, Department of Internal Medicine. Wayne State University School of Medicine.. Pathophysiology of COVID. Coronaviruses. Large, enveloped, single-stranded RNA viruses found in humans and other mammals. TREATMENT AND OUTCOMES OF COVID-19 IN THE US: ARE THEY DIFFERENT ACCORDING TO RACE?. Employment and stock options (Self)– Gilead Sciences. Introduction. Objective. Examine the use of COVID-19 treatments over time and by race in patients hospitalized with COVID-19 in the US. We aspire to excellence. We reflect, we learn, we improve. We respect and support one another. Northampton General Hospital NHS Trust. Post Covid-19 Reset. Chris Pallot, Director of Strategy and Partnerships. Natalie Marlowe. 1. , David Lam. 2. , Suthat Liangpunsakul. 3. . ConclusionS. We documented a significant increase in AH hospitalizations, in-hospital mortality, and healthcare cost and utilization among AH patients, notably in those who were...